Catalyst Wire Dossier Catalyst Wire Dossier

Autologous grafts containing stem cells genetically modified for epidermis restoration

· Holostem s.r.l.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous grafts containing stem cells genetically modified for epidermis restoration, covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa [Phase 2, Phase 3]

See pricing